Partnering, Pharma

Janssen signs a biotech deal with HalfPenny Technologies

Posted on 11 June 2014

Tags: , ,

Halfpenny Technologies has entered into an agreement with Janssen Diagnostics that will supplement the unique clinical data needs of Janssen’s AVIGA EHR.

The AVIGA electronic health record is uniquely designed to support the data and federal reporting needs of providers specializing in HIV/AIDS healthcare.

This agreement, utilizing Halfpenny’s intelligent integration technology hub and its core data normalization competencies supplements the wide range of services AVIGA provides its clients.

For further deal information visit Current Agreements (subscription required)



Report: Partnering Deals and Alliances with Johnson & Johnson / Janssen

Report: Hepatitis Partnering

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply